Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Gender, a biological determinant of mental health and illness, plays a critical role in determining patients' susceptibility, exposure to mental health risks, and related outcomes. Regarding sex differences in the epidemiology of opioid dependence, one third of the patients are women of childbearing age. Women have an earlier age of initiation of substance use and a more rapid progression to drug involvement and dependence than men. Generally few studies exist which focus on the special needs of women in opioid maintenance therapy. The aim of this paper is to provide an overview of treatment options for opioid-dependent women, with a special focus on buprenorphine, and to look at recent findings related to other factors that should be taken into consideration in optimizing the treatment of opioid-dependent women. Issues addressed include the role of gender in the choice of medication assisted treatment, sex differences in pharmacodynamics and pharmacokinetics of buprenorphine drug interactions, cardiac interactions, induction of buprenorphine in pregnant patients, the neonatal abstinence syndrome and breastfeeding. This paper aims to heighten the awareness for the need to take gender into consideration when making treatment decisions in an effort to optimize services and enhance the quality of life of women suffering from substance abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
μ-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05100.2002 · Cited by 363
Does retention matter? Treatment duration and improvement in drug use
Zhang, Z., Friedmann, P. D., & Gerstein, D. R. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00354.x · Cited by 314 · cited 1×
“15 , 17 , 18 Co-occurring psychiatric problems, such as mood disorders and past and present sexual abuse, were seen more frequently in drug-dependent pregnant women compared to a control female population.”
ResultAbdel-Latif, M. E., Pinner, J., Clews, S., Cooke, F., Lui, K., & Oei, J. (2006) · Pediatrics · doi:10.1542/peds.2005-1561 · Cited by 266 · cited 1×
“For methadone, recent reports have confirmed earlier findings that breastfeeding could serve as a means of diminishing duration of methadone associated NAS, 98 , 99 both from comfort obtained through mother/child bonding 91 and from the oral bioavailability of methadone.”
BackgroundTreatment of opioid-dependent pregnant women: Clinical and research issues
Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.10.007 · Cited by 191
Self-citationAltered methadone pharmacokinetics in methadone-maintained pregnant women.
Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., & Benowitz, N. L. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21130-2 · Cited by 189
Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes
Johnson, R. E., Jones, H. E., Jasinski, D. R., Svikis, D. S., Haug, N. A., Jansson, L. M., Kissin, W. B., Alpan, G., Lantz, M. E., Cone, E. J., et al. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00194-0 · Cited by 125
Cited by
Maternal self-harm deaths: an unrecognized and preventable outcome
Mangla, K., Hoffman, M. C., Trumpff, C., O’Grady, S., & Monk, C. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.056 · Cited by 215
“An estimated one third of opioiddependent patients in the United States are women of child-bearing age.(30) Opiates are particularly dangerous for women.”
BackgroundGender differences in pharmacokinetics of maintenance dosed buprenorphine
Moody, D. E., Fang, W. B., Morrison, J., & McCance-Katz, E. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.03.024 · Cited by 68
Non-Obstetric Maternal Mortality Trends by Race in the United States
Huang, R. S., Spence, A. R., & Abenhaim, H. A. (2024) · Maternal and Child Health Journal · doi:10.1007/s10995-023-03862-7 · Cited by 13
Metadata
- Authors
- Unger, A., Jung, E., Winklbaur, B., & Fischer, G.
- Venue
- Journal of Addictive Diseases
- Publisher
- Informa UK Limited
- Published
- 2010-04-16
- Volume
- 29
- Issue
- 2
- Pages
- 217-230
- ISSN
- 1055-0887 (ISSN-L)
- 1545-0848
- OpenAlex
- W2031982647
- Cited by
- 77
- References
- 6
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.